GL1X · GenesisL1 explorer

Research workbench

Co-crystallization of streptavidin-biotin complex with a lanthanide- ligand complex gives rise to a novel crystal form

Analyse Co-crystallization of streptavidin-biotin complex with a lanthanide- ligand… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4IRW
Type
protein
Length
123 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Streptavidin
UniProt
P22629
Ligands
PDC, BTN, TB, NA
Pockets
1 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AStreptavidinprotein1237% helix, 54% strandP22629

Ligands and binding sites

  • PDC · Pyridine-2,6-dicarboxylic acid · ligand · 12 copies · chains A
  • BTN · Biotin · ligand · chains A
  • TB · Terbium(iii) ion · metal · 5 copies · chains A
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1850.480.8218BTN

Compared structures

  • 4IRW · Co-crystallization of streptavidin-biotin complex with a lanthanide-ligand complex gives… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.